| |
| |
|
| Insider
Information: |
Gold Mitchell |
| Relationship: |
Executive Chairman and... |
| City: |
|
| State: |
|
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
2 |
|
| Direct
Shares |
457,263 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$0 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
457,263 |
|
|
| Total
Value |
$0 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Dendreon Corp |
DNDN |
Director |
2013-01-03 |
457,263 |
2003-09-03 |
0 |
Premium* |
|
|
Alpine Immune Sciences Inc |
ALPN |
Executive Chairman and... |
2024-05-20 |
0 |
2024-05-18 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
140 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 2 of 6
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| DNDN |
Dendreon Corp |
President & CEO |
• • – |
2007-10-19 |
4 |
D |
$7.62 |
$9,761 |
D/D |
(1,281) |
300,705 |
0 |
- |
|
| DNDN |
Dendreon Corp |
President & CEO |
• – – |
2009-07-19 |
4 |
D |
$22.99 |
$29,450 |
D/D |
(1,281) |
482,279 |
0 |
- |
|
| DNDN |
Dendreon Corp |
President & Chief Executive Of |
• • – |
2011-01-21 |
4 |
D |
$13.37 |
$17,127 |
D/D |
(1,281) |
669,776 |
0 |
- |
|
| DNDN |
Dendreon Corp |
President & Chief Executive Of |
• – – |
2011-04-21 |
4 |
D |
$40.89 |
$52,380 |
D/D |
(1,281) |
282,412 |
0 |
- |
|
| DNDN |
Dendreon Corp |
President & Chief Executive Of |
• – – |
2011-07-21 |
4 |
D |
$39.13 |
$50,126 |
D/D |
(1,281) |
244,785 |
0 |
- |
|
| DNDN |
Dendreon Corp |
President & Chief Executive Of |
• – – |
2011-10-21 |
4 |
D |
$10.36 |
$13,271 |
D/D |
(1,281) |
222,277 |
0 |
- |
|
| DNDN |
Dendreon Corp |
President & CEO |
• – – |
2009-10-19 |
4 |
D |
$29.20 |
$37,434 |
D/D |
(1,282) |
478,021 |
0 |
- |
|
| DNDN |
Dendreon Corp |
President & Chief Executive Of |
• – – |
2010-01-19 |
4 |
D |
$29.89 |
$38,319 |
D/D |
(1,282) |
459,734 |
0 |
- |
|
| DNDN |
Dendreon Corp |
President & CEO |
• • – |
2005-01-31 |
5 |
S |
$5.78 |
$8,849 |
D/D |
(1,531) |
46,511 |
0 |
- |
|
| DNDN |
Dendreon Corp |
President & Chief Executive Of |
• – – |
2010-01-17 |
4 |
D |
$29.05 |
$44,766 |
D/D |
(1,541) |
461,636 |
0 |
- |
|
| DNDN |
Dendreon Corp |
President & CEO |
• – – |
2009-07-17 |
4 |
D |
$22.99 |
$48,785 |
D/D |
(2,122) |
484,414 |
0 |
- |
|
| DNDN |
Dendreon Corp |
President & CEO |
• – – |
2009-10-17 |
4 |
D |
$29.51 |
$62,620 |
D/D |
(2,122) |
480,157 |
0 |
- |
|
| DNDN |
Dendreon Corp |
President & CEO |
• – – |
2010-04-17 |
4 |
D |
$38.90 |
$82,546 |
D/D |
(2,122) |
509,876 |
0 |
- |
|
| DNDN |
Dendreon Corp |
President & CEO |
• – – |
2010-07-17 |
4 |
D |
$31.29 |
$66,397 |
D/D |
(2,122) |
218,251 |
0 |
- |
|
| DNDN |
Dendreon Corp |
President & CEO |
• – – |
2010-10-17 |
4 |
D |
$37.83 |
$80,275 |
D/D |
(2,122) |
211,289 |
0 |
- |
|
| DNDN |
Dendreon Corp |
President & Chief Executive Of |
• – – |
2011-01-17 |
4 |
D |
$37.16 |
$78,854 |
D/D |
(2,122) |
239,680 |
0 |
- |
|
| DNDN |
Dendreon Corp |
President & Chief Executive Of |
• – – |
2011-04-17 |
4 |
D |
$42.40 |
$89,973 |
D/D |
(2,122) |
283,693 |
0 |
- |
|
| DNDN |
Dendreon Corp |
President & Chief Executive Of |
• – – |
2011-07-17 |
4 |
D |
$38.80 |
$82,334 |
D/D |
(2,122) |
246,066 |
0 |
- |
|
| DNDN |
Dendreon Corp |
President & Chief Executive Of |
• – – |
2011-10-17 |
4 |
D |
$9.31 |
$19,756 |
D/D |
(2,122) |
223,558 |
0 |
- |
|
| ALPN |
Alpine Immune Sciences In... |
Executive Chairman and CEO |
• • – |
2023-12-19 |
4 |
AS |
$20.01 |
$48,064 |
D/D |
(2,402) |
0 |
0 |
% |
|
| ALPN |
Alpine Immune Sciences In... |
Executive Chairman and CEO |
• • – |
2023-12-19 |
4 |
OE |
$0.45 |
$1,081 |
D/D |
2,402 |
2,402 |
0 |
- |
|
| DNDN |
Dendreon Corp |
President & CEO |
• – – |
2012-04-15 |
4 |
D |
$8.85 |
$25,603 |
D/D |
(2,893) |
631,883 |
0 |
- |
|
| ALPN |
Alpine Immune Sciences In... |
Executive Chairman and CEO |
• • • |
2018-05-14 |
4 |
GD |
$0.00 |
$0 |
D/D |
3,000 |
20,292 |
0 |
- |
|
| ALPN |
Alpine Immune Sciences In... |
Executive Chairman and CEO |
• • • |
2018-05-15 |
4 |
GD |
$0.00 |
$0 |
D/D |
3,000 |
17,292 |
0 |
- |
|
| DNDN |
Dendreon Corp |
President & CEO |
• • – |
2008-01-18 |
4 |
D |
$6.43 |
$19,599 |
D/D |
(3,048) |
390,837 |
0 |
- |
|
140 Records found
|
|
Page 2 of 6 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
